Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00965523
What this trial is testing

Study of E7389 for Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eisai Co., Ltd. 81
Large-scale testing (Phase 3)Study completedNCT03425656
What this trial is testing

Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer

Who this might be right for
Malignant Neoplasm of Breast
AryoGen Pharmed Co. 108
Not applicableUnknownNCT05241925
What this trial is testing

Effects of Continuous and Interval Physical Training Through the Intensity of the Incremental Shuttle Walk Test, on Functional Capacity and Quality of Life in Women With Malignant Breast Cancer During Chemotherapy Treatment

Who this might be right for
Breast Cancer FemaleExercise Addiction
University of Nove de Julho 60
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04768426
What this trial is testing

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
Stanford University 40
Early research (Phase 1)Study completedNCT00978913
What this trial is testing

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

Who this might be right for
Breast CancerMalignant Melanoma
Inge Marie Svane 31
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT01509625
What this trial is testing

Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

Who this might be right for
Malignant Neoplasm of Breast Stage IV
Isabel Blancas 272
Large-scale testing (Phase 3)Study completedNCT00201435
What this trial is testing

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

Who this might be right for
Breast Neoplasm
Norwegian Breast Cancer Group 224
Not applicableUnknownNCT03969524
What this trial is testing

Functional MRI in Predicting Response to Chemotherapy

Who this might be right for
Breast Cancer Patients
Assiut University 50
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT05159778
What this trial is testing

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Who this might be right for
Malignant Neoplasm of Breast
HiberCell, Inc. 26
Not applicableStudy completedNCT02561468
What this trial is testing

The Preemptive Analgesic Efficacy of Nefopam

Who this might be right for
Breast Neoplasm
Seoul National University Bundang Hospital 94
Testing effectiveness (Phase 2)Study completedNCT00530868
What this trial is testing

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Who this might be right for
Breast CancerCancer of the BreastBreast Neoplasm
University of Alabama at Birmingham 75
Testing effectiveness (Phase 2)Study completedNCT01118624
What this trial is testing

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Who this might be right for
Breast CancerBreast TumorsNeoplasms, Breast+2 more
Acrotech Biopharma Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05392608
What this trial is testing

SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

Who this might be right for
Neoplasm, BreastCongenital, Familial and Genetic Disorders
Borstkanker Onderzoek Groep 130
Testing effectiveness (Phase 2)Ended earlyNCT02598310
What this trial is testing

Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Negative NeoplasmHER-2 Positive Breast Cancer
Osaka Medical College 30
Testing effectiveness (Phase 2)Study completedNCT00377559
What this trial is testing

Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Catharina Ziekenhuis Eindhoven 70
Early research (Phase 1)Looking for participantsNCT07046923
What this trial is testing

LY4175408 in Participants With Advanced Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more
Eli Lilly and Company 240
Not applicableLooking for participantsNCT03463954
What this trial is testing

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Who this might be right for
Malignant Neoplasm of Breast
Novian Health Inc. 122
Next Page